rdf:type |
|
lifeskim:mentions |
umls-concept:C0001563,
umls-concept:C0026809,
umls-concept:C0030956,
umls-concept:C0242633,
umls-concept:C0871261,
umls-concept:C1423842,
umls-concept:C1521761,
umls-concept:C1527180,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
pubmed:issue |
6 Pt 1
|
pubmed:dateCreated |
1999-1-19
|
pubmed:abstractText |
Oral immunotherapy with a peptide for allergic immune responses is theoretically a promising therapy but has not been established yet.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Allergens,
http://linkedlifedata.com/resource/pubmed/chemical/Cholera Toxin,
http://linkedlifedata.com/resource/pubmed/chemical/Cry j II protein, Cryptomeria...,
http://linkedlifedata.com/resource/pubmed/chemical/Epitopes, T-Lymphocyte,
http://linkedlifedata.com/resource/pubmed/chemical/Immunodominant Epitopes,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin E,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/Plant Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0091-6749
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
102
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
961-7
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9847437-Administration, Intranasal,
pubmed-meshheading:9847437-Administration, Oral,
pubmed-meshheading:9847437-Allergens,
pubmed-meshheading:9847437-Animals,
pubmed-meshheading:9847437-Cells, Cultured,
pubmed-meshheading:9847437-Cholera Toxin,
pubmed-meshheading:9847437-Epitopes, T-Lymphocyte,
pubmed-meshheading:9847437-Female,
pubmed-meshheading:9847437-Immune Tolerance,
pubmed-meshheading:9847437-Immunodominant Epitopes,
pubmed-meshheading:9847437-Immunoglobulin E,
pubmed-meshheading:9847437-Immunoglobulin G,
pubmed-meshheading:9847437-Lymph Nodes,
pubmed-meshheading:9847437-Lymphocyte Activation,
pubmed-meshheading:9847437-Mice,
pubmed-meshheading:9847437-Mice, Inbred BALB C,
pubmed-meshheading:9847437-Nasal Mucosa,
pubmed-meshheading:9847437-Peptides,
pubmed-meshheading:9847437-Plant Proteins,
pubmed-meshheading:9847437-Pollen,
pubmed-meshheading:9847437-Th1 Cells,
pubmed-meshheading:9847437-Th2 Cells,
pubmed-meshheading:9847437-Trees
|
pubmed:year |
1998
|
pubmed:articleTitle |
Oral administration of a dominant T-cell determinant peptide inhibits allergen-specific TH1 and TH2 cell responses in Cry j 2-primed mice.
|
pubmed:affiliation |
Sankyo Co, Ltd, Tokyo.
|
pubmed:publicationType |
Journal Article
|